791
Views
7
CrossRef citations to date
0
Altmetric
Short Report

Listeria monocytogenes mutants defective in gallbladder replication represent safety-enhanced vaccine delivery platforms

, , , , &
Pages 2059-2063 | Received 09 Dec 2015, Accepted 10 Feb 2016, Published online: 02 Apr 2016

References

  • Hamon M, Bierne H, Cossart P. Listeria monocytogenes: a multifaceted model. Nat Rev Microbiol 2006; 4:423-434; PMID:16710323; http://dx.doi.org/10.1038/nrmicro1413
  • Vazquez-Boland JA, Kuhn M, Berche P, Chakraborty T, Dominguez-Bernal G, Goebel W, Gonzalez-Zorn B, Wehland J, Kreft J. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 2001; 14:584-640; PMID:11432815; http://dx.doi.org/10.1128/CMR.14.3.584-640.2001
  • Shahabi V, Maciag PC, Rivera S, Wallecha A. Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment. Bioeng Bugs 2010; 1:235-243; PMID:21327055; http://dx.doi.org/10.4161/bbug.1.4.11243
  • Tangney M, van Pijkeren JP, Gahan CG. The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy. Bioeng Bugs 2010; 1:284-287; PMID:21327062; http://dx.doi.org/10.4161/bbug.1.4.11725
  • Kursar M, Bonhagen K, Kohler A, Kamradt T, Kaufmann SH, Mittrucker HW. Antigen-specific CD8+ T cell responses in intestinal tissues during murine listeriosis. Microbes Infect 2004; 6:8-16; PMID:14738888; http://dx.doi.org/10.1016/j.micinf.2003.10.004
  • Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004; 4:812-823; PMID:15459672; http://dx.doi.org/10.1038/nri1461
  • von Koenig CH, Finger H, Hof H. Failure of killed Listeria monocytogenes vaccine to produce protective immunity. Nature 1982; 297:233-234; PMID:6176874; http://dx.doi.org/10.1038/297233a0
  • Bahey-El-Din M, Casey PG, Griffin BT, Gahan CG. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model. Vaccine 2008; 26:5304-5314; PMID:18691625; http://dx.doi.org/10.1016/j.vaccine.2008.07.047
  • van Pijkeren JP, Morrissey D, Monk IR, Cronin M, Rajendran S, O'Sullivan GC, Gahan CG, Tangney M. A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Hum Gene Ther 2010; 21:405-416; PMID:20105075; http://dx.doi.org/10.1089/hum.2009.022
  • Brockstedt DG, Giedlin MA, Leong ML, Bahjat KS, Gao Y, Luckett W, Liu W, Cook DN, Portnoy DA, Dubensky TW, Jr. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci U S A 2004; 101:13832-13837; PMID:15365184; http://dx.doi.org/10.1073/pnas.0406035101
  • Radulovic S, Brankovic-Magic M, Malisic E, Jankovic R, Dobricic J, Plesinac-Karapandzic V, Maciag PC, Rothman J. Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C. J BUON 2009; 14 Suppl 1:S165-168; PMID:19785060
  • Maciag PC, Radulovic S, Rothman J. The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine 2009; 27:3975-3983; PMID:19389451; http://dx.doi.org/10.1016/j.vaccine.2009.04.041
  • Le DT, Wang-Gillam A, Picozzi V, Greten TF, Crocenzi T, Springett G, Morse M, Zeh H, Cohen D, Fine RL, et al. Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol 2015; 33:1325-1333; PMID:25584002; http://dx.doi.org/10.1200/JCO.2014.57.4244
  • Sacco JJ, Evans M, Harrington KJ, Man S, Powell N, Shaw RJ, Jones TM. Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001. Hum Vaccin Immunother 2015:0. [Epub ahead of print].
  • Hardy J, Francis KP, DeBoer M, Chu P, Gibbs K, Contag CH. Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 2004; 303:851-853; PMID:14764883; http://dx.doi.org/10.1126/science.1092712
  • Bron PA, Monk IR, Corr SC, Hill C, Gahan CG. Novel luciferase reporter system for in vitro and organ-specific monitoring of differential gene expression in Listeria monocytogenes. Appl Environ Microbiol 2006; 72:2876-2884; PMID:16597994; http://dx.doi.org/10.1128/AEM.72.4.2876-2884.2006
  • Hardy J, Margolis JJ, Contag CH. Induced biliary excretion of Listeria monocytogenes. Infect Immun 2006; 74:1819-1827; PMID:16495556; http://dx.doi.org/10.1128/IAI.74.3.1819-1827.2006
  • Charlier C, Fevre C, Travier L, Cazenave B, Bracq-Dieye H, Podevin J, Assomany D, Guilbert L, Bossard C, Carpentier F, et al. Listeria monocytogenes-associated biliary tract infections: a study of 12 consecutive cases and review. Medicine (Baltimore) 2014; 93:e105; PMID:25319439; http://dx.doi.org/10.1097/MD.0000000000000105
  • Gahan CG, Hill C. Listeria monocytogenes: survival and adaptation in the gastrointestinal tract. Front Cell Infect Microbiol 2014; 4:9; PMID:24551601; http://dx.doi.org/10.3389/fcimb.2014.00009
  • Dowd GC, Joyce SA, Hill C, Gahan CG. Investigation of the mechanisms by which Listeria monocytogenes grows in porcine gallbladder bile. Infect Immun 2011; 79:369-379; PMID:20937762; http://dx.doi.org/10.1128/IAI.00330-10
  • McLaughlin HP, Xiao Q, Rea RB, Pi H, Casey PG, Darby T, Charbit A, Sleator RD, Joyce SA, Cowart RE, et al. A putative P-type ATPase required for virulence and resistance to haem toxicity in Listeria monocytogenes. PLoS One 2012; 7:e30928; PMID:22363518; http://dx.doi.org/10.1371/journal.pone.0030928
  • Bahey-El-Din M, Casey PG, Griffin BT, Gahan CG. Efficacy of a Lactococcus lactis DeltapyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes. Bioeng Bugs 2010; 1:66-74; PMID:21327128
  • Bahey-El-Din M, Casey PG, Griffin BT, Gahan CG. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors. J Med Microbiol 2010; 59:904-912; PMID:20488938; http://dx.doi.org/10.1099/jmm.0.018770-0
  • Bahey-El-Din M, Gahan CG. Vaccination studies: detection of a Listeria monocytogenes-specific T cell immune response using the ELISPOT technique. Methods Mol Biol 2014; 1157:263-274; PMID:24792565; http://dx.doi.org/10.1007/978-1-4939-0703-8_22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.